Ascorbic acid deficiency in liver disease.
Leucocyte ascorbic acid (LAA) levels were measured in 138 patients with liver disease. Significantly reduced levels were found in 37 patients with alcoholic liver disease (P less than 0-01) and 25 patients with primary biliary cirrhosis (P less than 0-05). In the primary biliary cirrhosis patients, cholestyramine therapy was associated with significantly lower levels of the vitamin (P less than 0-05). Liver ascorbic acid measured in Menghini needle biopsies in 20 patients was significantly correlated with LAA (r=0-807, P less than 0-001). No significant correlation was found between LAA and haematological indices, conventional liver function tests, or cholesterol levels in any group of patients. Patients with LAA levels below 100 nM/10(8) WBC had significantly higher antipyrine half-lives (mean=28-3 h) than patients with LAA levels above this level (mean=18-6 h) (P less than 0-05). Delayed drug metabolism related to low LAA should be considered when drugs metabolised by the liver are prescribed for patients with alcoholic liver disease or primary biliary cirrhosis.
D000437:Alcoholism / Q000150:complications*; D001205:Ascorbic Acid / Q000097:blood / Q000378:metabolism; D001206:Ascorbic Acid Deficiency / Q000150:complications*; D002792:Cholestyramine Resin / Q000378:metabolism; D006801:Humans; D007962:Leukocytes / Q000032:analysis; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000150:complications*; D008105:Liver Cirrhosis, Biliary / Q000150:complications*; D008111:Liver Function Tests
D002792:Cholestyramine Resin; D001205:Ascorbic Acid